Ivan P. Gergel, SVP & Chief Medical Officer at NEKTAR THERAPEUTICS (NKTR), sold 90,160 shares at $21.09 ($1.9M) on 2017-07-12, disclosed to the SEC on 2017-07-13.
Open-market sale of $1.9M NKTR by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.04 | 8,389 | $177K | 9.3% |
| 2 | $21.04 | 8,389 | $177K | 9.3% |
| 3 | $21.09 | 36,691 | $774K | 40.7% |
| 4 | $21.09 | 36,691 | $774K | 40.7% |
| Total | $21.08 avg | 90,160 | $1.9M | 100% |
| Filing → |
| NKTR | SELL | 2017-07-20 | $1.2M | — | Filing → |
| NKTR | SELL | 2017-05-18 | $28K | — | Filing → |
| NKTR | SELL | 2017-02-17 | $19K | — | Filing → |